Skip to main content
News

FDA warns of rare vision-loss side effect from GLP-1 drugs

FDA warns of rare vision-loss side effect from GLP-1 drugs

Feed excerpt — reported by CBS News

The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at CBS News →

Original Source

This article was syndicated from CBS News. All rights remain with the original publisher.